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Ouabain induces endocytosis of plasmalemmal Na/K-ATPase
in LLC-PK1 cells by a clathrin-dependent mechanism.
Background. We have demonstrated that ouabain causes
dose- and time-dependent decreases in 86Rb uptake in porcine
proximal tubular (LLC-PK1) cells. The present study addresses
the molecular mechanisms involved in this process.
Methods. Studies were performed with cultured LLC-PK1
and Src family kinase deficient (SYF) cells.
Results. We found that 50 nmol/L ouabain applied to the
basal, but not apical, aspect for 12 hours caused decreases in the
plasmalemmal Na/K-ATPase. This loss of plasmalemmal Na/K-
ATPase reverses completely within 12 to 24 hours after removal
of ouabain. Ouabain also increased the Na/K-ATPase con-
tent in both early and late endosomes, activated phosphatidyli-
nositol 3-kinase (PI(3)K), and also caused a translocation
of some Na/K-ATPase to the nucleus. Immunofluorescence
demonstrated that the Na/K-ATPase colocalized with clathrin
both before and after exposure to ouabain, and immunoprecip-
itation experiments confirmed that ouabain stimulated interac-
tions among the Na/K-ATPase, adaptor protein-2 (AP-2), and
clathrin. Potassium (K) depletion, chlorpromazine, or PI(3)K
inhibition all significantly attenuated this ouabain-induced
endocytosis. Inhibition of the ouabain-activated signaling
process through Src by 4-Amino-5-(4-chlorophenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine (PP2) significantly attenuated
ouabain-induced endocytosis. Moreover, experiments per-
formed in SYF cells demonstrated that ouabain induced in-
creases in the endocytosis of the Na/K-ATPase when Src was
reconstituted (SYF+), but not in the Src-deficient (SYF−) cells.
Conclusion. These data demonstrate that ouabain stimulates
a clathrin-dependent endocytosis pathway that translocates the
Na/K-ATPase to intracellular compartments, thus suggesting a
potential role of endocytosis in ouabain-induced signal trans-
duction as well as proximal tubule sodium handling.
Renal sodium handling involves a complex interplay
of different hormonal systems and physical factors; this
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topic has fascinated scientists for a number of years [1].
In the proximal tubule cell, the Na/K-ATPase resides at
the basolateral surface, where it provides the force for the
vectorial transport of sodium from the tubular lumen to
the blood compartment [2]. The cellular distribution of
the Na/K-ATPase is thought to be crucial for this func-
tion. Digoxin and ouabain, substances of plant origin, in-
hibit Na/K-ATPase activity by binding to an extracellular
portion of the Na/K-ATPase a-subunit [3]. The fact that
substances of plant origin specifically affect the activity
of an important animal cell enzyme naturally led to the
idea that animals may have endogenous digitalis-like sub-
stances (DLS) that can specifically regulate the activity
of Na/K-ATPase. During the 1960s, it was postulated that
one or more circulating inhibitors of the Na/K-ATPase,
also called “3rd factor,” were important in the regula-
tion of renal sodium handling [4]. Recent studies have
demonstrated that substances that are structurally simi-
lar to ouabain-like compound (OLC) as well as marinob-
ufagenin (MBG) are increased in the serum and urine of
experimental animals and patients who are volume ex-
panded [5–8]. Moreover, in some cases, the increases in
the concentrations of OLC and MBG correlate with in-
creases in renal sodium excretion [9]. DLS are also found
in the hypothalamus and adrenal glands of animals [10].
We have previously reported that in LLC-PK1 but
not Madin-Darby canine kidney (MDCK) cells, ouabain
administration for 12 hours decreases 86Rb uptake by
50% at concentrations less than 1/20th of that neces-
sary to acutely (30 minutes) inhibit 86Rb uptake by 50%
(IC50). We have proposed that this mechanism might ex-
plain how DLS circulating at concentrations of 10−9mol/L
could substantially alter proximal tubule sodium handling
in vivo [11]. Interestingly, regulation of Na/K-ATPase ac-
tivity by dopamine also appears to require endocytosis of
the enzyme [12, 13].
The clathrin-dependent pathway of endocytosis is
clearly the best-characterized endocytosis pathway for
membrane proteins in mammalian cells, although our un-
derstanding of caveolin-dependent processes is certainly
expanding [14]. This clathrin-dependent endocytosis
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pathway involves the delivery of cell surface components
and solutes to early endosomes. After this, endocytosed
components are either recycled back to the plasma mem-
brane for reuse or transported to the late endosomes and
lysosomes for degradation [15]. Our recent work indi-
cates that the Na/K-ATPase can function as a signal trans-
ducer, leading to the activation of a signal transduction
cascade involving Src and endothelial growth factor re-
ceptor (EGFR) [16–18]. Because many other membrane
receptor ligands activate clathrin-mediated endocytosis
of the receptor coincident with stimulation [19], we sus-
pected that ouabain might also produce such an effect.




Chemicals of the highest purity available were ob-
tained from Sigma (St. Louis, MO, USA). Radioactive
rubidium (86Rb) was obtained from Dupont NEN
Life Science Products (Boston, MA, USA). EZ-
Kink sulfo-NHS-ss-Biotin and ImmunoPure immobi-
lized streptavidin-agarose beads were obtained from
Pierce Biotechnology (Rockford, IL, USA). Wortman-
nin and LY294002 were obtained from CalBiochem (La
Jolla, CA, USA). Optitran nitrocellulose and polyvinyli-
dine difluoride (PVDF) membranes (Hybound-P) were
obtained from Schleicher&Schuell (Keene, NH, USA)
and Amersham Biosciences (Piscataway, NJ, USA),
respectively.
Polyclonal and monoclonal antibodies against Na/K-
ATPase a1 subunit (clone C464.6), EEA-1, anti PI-3K
p85a antibody coupled to protein A-agarose, and AP-
2 a subunit (clone 8G8/5) were obtained from Upstate
Biotechnology (Lake Placid, NY, USA). Monoclonal an-
tibodies against clathrin heavy chain (CHC, clone X22)
were obtained from Affinity BioReagents (Golden, CO,
USA), and were used in the immunoprecipitation exper-
iments. Polyclonal antibodies against CHC, Rab5, Rab7,
as well as horseradish peroxidase–conjugated goat an-
timouse and goat antirabbit IgG obtained from Santa
Cruz Biotechnology (Santa Cruz, CA, USA) were used
for Western blot. Monoclonal antibody against Na/K-
ATPase a1 subunit (clone a6F) obtained from Hy-
bridoma Bank (University of Iowa, Iowa City, IA, USA)
and polyclonal anti-clathrin antibodies obtained from BD
Transduction Laboratories (San Diego, CA, USA) were
used for immunofluorescence studies. Alexa Fluor 488-
or Alexa Fluor 546-conjugated antimouse or antirab-
bit secondary antibodies were obtained from Molecular
Probes (Eugene, OR, USA). Normal mouse IgG and rab-
bit IgG were purchased from Sigma.
Cell culture
The pig renal proximal tubule cell line, LLC-PK1, was
obtained from the American Tissue Type Culture Col-
lection (Manassas, VA, USA), and cultured to confluent
condition as previously described [11]. Cell viability was
evaluated by Trypan blue exclusion. In some experiments,
LLC-PK1 cells were grown to confluence (6 to 7 days) on
the 12- or 24-mm polycarbonate Transwell culture filter
inserts (filter pore size 0.4 lm; Costar Co., Cambridge,
MA, USA). Medium was replaced daily until 12 hours
before experiments, at which time the monolayer was
serum starved as reported previously [11]. For some se-
lect experiments, we used SYF− cells lacking functional
Src, as well as SYF+ cells in which Src was reconstituted
as we have previously described [17]. The SYF− cells are
derived from mouse embryos harboring functional null
mutations in both alleles of the Src family kinases Src,
Yes, and Fyn. The SYF+ cells are SYF− cells that have
been stably transfected to express c-Src [20]. These cells
were also obtained from ATCC. SYF cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM) with
10% fetal bovine serum (FBS). Medium was changed
daily until the cells reached 80% to 90% confluence, at
which time the medium was changed to DMEM with
1% FBS for at least 12 hours before experiments. SYF
cells are not viable if they are completely serum starved
[20].
Ouabain-sensitive Na/K-ATPase activity assay
(86Rb uptake)
Ouabain-sensitive uptake 86Rb uptake (of LLC-PK1
cells grown to monolayer) was performed as previously
described [11]. The 86Rb uptake was calibrated with pro-
tein content. Data were expressed as the percentage of
control ouabain-sensitive 86Rb uptake.
Western blot
Proteins were separated by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
or NuPAGE 4% to 12% Bis-Tris gels (Invitrogen, Carls-
bad, CA, USA), and transferred to Optitran or PVDF
membrane. After transfer, the gel was stained with
Coomassie Brilliant Blue to verify uniform loading and
transfer. Immunoblotting was performed as described
previously. Detection was performed with the enhanced
chemiluminescence (ECL) super signal kit (Pierce). Mul-
tiple exposures were analyzed to assure that the signals
were within the linear range of the film. Autoradiograms
were scanned with a Bio-Rad GS-670 imaging densitome-
ter (Bio-Rad, Hercules, CA, USA) to quantify the signals
[11].






Fig. 1. Representative Western blots of EAA-1, Rab5, Rab7, and
Lamin B. Lane 1 was loaded with protein from 16%/10% sucrose inter-
face (early endosomes), lane 2 with protein from 10%/buffer interface
(late endosomes), and lane 3 with protein from nuclear fraction. All
lanes were loaded with 10 lg of protein. In N = 3 studies, EAA-1 and
Rab5 contents in the early endosomes were more than 10× that seen in
late endosomes, and conversely, Rab7 content in late endosomes was
more than 10× that seen in early endosomes. Lamin B appeared to be
essentially confined to the nuclear fraction, and the nuclear fraction did
not contain any detectable Rab5, Rab7, or EAA-1 in each of these three
samples.
Subcellular fractionation
Nuclear fraction was isolated as previously described
[11]. We stress that this methodology uses both a 2 mol/L
sucrose cushion, as well as multiple washings, to minimize
contamination of the nuclear compartment with either
plasmalemma or endosomes. We were unable to detect
either Rab 5 or Rab 7 (markers of early and late endo-
somes, see below) in the nuclear fraction of either normal
or ouabain-stimulated cells; conversely, Lamin B was eas-
ily detected in the nuclear fraction (Fig. 1).
Preparation of endosomes
Endosomes were fractionated on a flotation gradient
using the technique of Gorvel et al [21]. Briefly, con-
trol and treated cells were washed twice with ice-cold
phosphate-buffered saline (PBS)-Ca-Mg (PBS contain-
ing 100 lmol/L CaCl2 and 1 mmol/L MgCl2), and once
with ice-cold PBS. The cells were collected in PBS and
centrifuged at 4◦C at 3000g for 5 minutes. The pellet
was resuspended in 3 mL of the homogenization buffer
(250 mmol/L sucrose in 3 mmol/L imidazole, pH 7.4)
and recentrifuged at 4◦C at 3000g for 10 minutes. The
pellet was resuspended in 1.0 mL of homogenization
buffer (with 10 lg/mL aprotinin, 10 lg/mL leupeptin,
1 mmol/L PMSF, and 0.5 mmol/L EDTA), and gen-
tly homogenized on ice using a Dounce homogenizer
(15 to 20 strokes), followed by a centrifugation (4◦C
at 3000g for 10 minutes). The supernatant was ad-
justed to 46% sucrose using a stock solution of 62%
sucrose in 3 mmol/L imidazole (pH 7.4) and loaded at
the bottom of a centrifuge tube, to which was sequen-
tially added 16% sucrose (4 mL) in 3 mmol/L imidazole
and 0.5 mmol/L EDTA in 2H2O, 10% sucrose in the
same buffer (3 mL), and finally homogenization buffer
(1 mL). The gradient was centrifuged at 4◦C at 130,000g
in a Beckmann SW 40Ti rotor for 60 minutes. Early endo-
somes were collected at the 16%/10% sucrose interface,
while the late endosomes were collected at the homoge-
nization buffer and 10% sucrose interface. The identity
of early and late endosomes was determined with poly-
clonal antibodies raised against Rab5, Rab7, and EEA-1
(Fig. 1).
Preparation of clathrin-coated vesicles (CCV)
Isolation of CCV was performed as described by Ham-
mond and Verroust [22]. Briefly, LLC-PK1 cells were col-
lected and homogenized using a Potter homogenizer in
isolation buffer (EGTA, 1 mmol/L; MgCl2, 0.5 mmol/L;
NaN3, 0.02%; 2-(N-morpholino) ethanesulfonic acid,
100 mmol/L; pH 6.5). The homogenate was centrifuged
at 15,000g for 15 minutes, and the supernatant was fur-
ther centrifuged at 85,000g for 60 minutes (with the addi-
tion of 1 mmol/L PMSF, 1 mmol/L sodium orthovanadate,
10 lg/mL leupeptin, and 10 lg/mL aprotinin). The pellet
was resuspended in isolation buffer, applied to a discon-
tinuous sucrose gradient (wt/vol in the same buffer, 60,
50, 40, 10, and 5%), and centrifuged at 80,000g for 75 min-
utes in a SW41Ti rotor. Samples were collected from the
10%/40% interface, washed, and resuspended in isola-
tion buffer, and pelleted at 85,000g for 60 minutes. Wheat
germ agglutinin (1 mg to 10 mg protein) was added and in-
cubated overnight at 4◦C, then centrifuged at 20,000g for
15 minutes. The supernatant was centrifuged at 165,000g
for 60 minutes, and the resulting pellet was resuspended
in the isolation buffer [22].
Labeling of cell surface Na/K-ATPase by biotinylation
Cell surface biotinylation was performed as previously
described [11, 23, 24]. Proteins bound to the ImmunoPure
immobilized streptavidin-agarose beads were eluted by
incubation at 55◦C water bath for 30 minutes with an
equal volume of 2× Laemmli sample buffer, and then
resolved on SDS-PAGE followed by immunoblotting.
For the biotinylation pulse-chase studies, LLC-PK1
cells were first biotinylated under the same conditions
described above (except that the biotinylation buffer pH
was adjusted down to 8.0, which we found did not affect
cell viability), quenched with PBS-Ca-Mg-glycine, and
brought back to normal incubation conditions in DMEM
in the presence or absence of ouabain for different times.
Immunoprecipitation of a1-subunit of Na/K-ATPase,
clathrin, and clathrin-associated protein AP-2
Immunoprecipitation of a1-subunit, AP-2 a-subunit,
and CHC proceeded mainly as described [17, 25, 26].
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Briefly, after washing (2×) with PBS-Ca-Mg and with
PBS, cells were solubilized in TGH buffer (1% Tri-
ton X-100, 0.25% sodium deoxycholate, 10% glycerol,
50 mmol/L NaCl, 50 mmol/L HEPES, pH 7.3, 1 mmol/L
EGTA, 1 mmol/L sodium orthovanadate, 1 mmol/L
PMSF, 10 lg/mL leupeptin, 10 lg/mL aprotinin).
After brief centrifugation (13,000g for 15 minutes), su-
pernatants containing equal amounts of protein were
immunoprecipitated with a saturating amount of anti-
bodies against a1 subunit, CHC, or AP-2 a subunit at
4◦C overnight with end-to-end rotation, and then 2 hours
with Protein A or G-agarose beads (Upstate). Immuno-
precipitates were washed (3×) with TGH and with PBS.
Proteins were eluted as described above, and resolved on
SDS-PAGE followed by immunoblotting. Normal rabbit
or mouse IgG was used as a control.
Confocal microscopy
Cells grown to confluence on the 12-mm Transwell fil-
ters were fixed and permeabilized as described by Muth
et al [27]. Briefly, cells were fixed with cold absolute
methanol or 4% paraformaldehyde in PBS, permeabi-
lized in permeabilization buffer [PBS-Ca-Mg with 0.3%
Triton X-100 and 0.1% bovine serum albumin (BSA),
freshly prepared] for 15 minutes, and blocked with GSDB
buffer [20 mmol/L sodium phosphate, pH 7.4, with 150
mmol/L NaCl, 0.3% Triton X-100, and 16% (v/v) fil-
tered normal goat or horse serum] for 30 minutes at
room temperature. The cells were then probed with pri-
mary antibody for 90 minutes at room temperature or
overnight at 4◦C (monoclonal anti a1 antibody, Upstate;
polyclonal anti-clathrin antibody, BD Transduction Lab-
oratories; 1:100 dilution in GSDB). After 3 washes with
permeabilization buffer, the cells were incubated with
Alexa Fluor 488- or Alexa Fluor 546-conjugated an-
timouse or antirabbit secondary antibody for 1 hour at
room temperature. After another 3 washes, specimens
were mounted using Prolong Anti-fade medium (Molec-
ular Probes) and stored at −20◦C. In some cases, the cells
were counterstained with propidium iodide (Molecular
Probes) to localize nuclei. All images were generated
with a Bio-Rad Radiance2000 laser scanning confocal
microscope (Bio-Rad). Contrast and brightness were set
to ensure that all pixels were within the linear range. The
software LaserSharp 2000 (Bio-Rad) was used for image
acquisition, storage, and visualization. Negative controls




Determination of PI(3)K was performed as described
by Chibalin et al [28] with minor modifications. Briefly,
after preincubation with ouabain under different con-
ditions, the cells were homogenized in 400 lL of ice-
cold lysis buffer [140 mmol/L NaCl, 10 mmol/L HEPES,
10 mmol/L sodium pyrophosphate, 1 mmol/L NaF,
1 mmol/L CaCl2, 1 mmol/L MgCl2, 1 mmol/L Na3VO4,
10% glycerol, 1% Nonidet P-40, 10 lg/mL aprotinin and
leupeptin, and 1 mmol/L PMSF, (pH 8.1)] and solubilized
by continuous stirring for 1 hour at 4◦C. After centrifu-
gation, 1 mg of supernatant protein was immunopre-
cipitated with an anti-PI-3K p85a antibody coupled to
protein A-agarose beads (Upstate). The immunopre-
cipitates were washed 4 times with washing buffer
[100 mmol/L NaCl, 1 mmol/L Na3VO4, and 20 mmol/L
HEPES (pH 7.5)] and resuspended in 40 lL of resuspen-
sion buffer [180 mmol/L NaCl and 20 mmol/L HEPES
(pH 7.5)]. The PI(3)K activity in the immunoprecipitate
was assessed directly on the protein A-agarose beads.
The reaction was initiated by addition of 20 lL of re-
action buffer [50 mmol/L NaCl, 0.015% Nonidet P-40,
12.5 mmol/L MgCl2, 250 lmol/L [c-32P]ATP (50 lCi),
1.0 mg/mL phosphatidylinositol (Avanti Biochemicals,
Birmingham, AL, USA), and 20 mmol/L HEPES (pH
7.5)]. The samples were incubated for 15 minutes at
room temperature, and the reaction was terminated by
sequential addition of 80 lL of 1 mol/L HCl and 160 lL
of chloroform/methanol (1:1, vol/vol). After vigorous
vortexing and a brief centrifugation, 40 lL of the lower
phase was spotted on aluminum-backed Silica Gel 60
thin layer chromatography plates (Sigma). The lipids
were resolved by 1-propanol/2 mol/L acetic acid (65:35,
vol/vol). The bands corresponding to phosphatidylinosi-
tol 3-phosphate were analyzed by autoradiography and
quantified using phosphoimaging (Typhoon 8600, Molec-
ular Dynamics, Sunnyvale, CA, USA).
Chlorpromazine treatment
LLC-PK1 cells were pretreated with 50 lmol/L of
chlorpromazine for 30 minutes at 37◦C, and then treated
with ouabain for indicated time as previously reported
[29, 30]. The chlorpromazine concentration and times of
incubation were chosen so that the cell viability was not
affected.
Intracellular potassium depletion treatment
Intracellular potassium depletion was carried out
as previously described by Larkin et al [31]. Briefly,
LLC-PK1 cells were washed twice with PBS-Ca-Mg
and incubated for 5 minutes at 37◦C in hypotonic
medium (DMEM/water, 1:1, vol/vol). The cells were then
washed with isotonic K+-free buffer (100 mmol/L NaCl,
0.1 mmol/L CaCl2, 1 mmol/L MgCl2, and 50 mmol/L
HEPES, pH 7.4), and incubated at 37◦C in the same
medium to produce potassium depletion. This potassium-
free media was then used for ouabain treatment
experiments. More than 90% of the cells were viable at
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the end of each experiment as assessed by Trypan blue
exclusion.
Statistical analysis
Data were first tested for normality (all data passed)
and then subjected to parametric analysis. When more
than two groups were compared, one-way analysis of vari-
ance (ANOVA) was performed before comparison of
individual groups with the unpaired Student t test with
Bonferroni’s correction for multiple comparisons. If only
two groups of normal data were compared, the Stu-
dent t test was used without correction. SPSS software
(Chicago, IL, USA) was used for all analyses.
RESULTS
Nontoxic concentration of ouabain inhibits the activity
of Na/K-ATPase via the endocytosis of the Na/K-ATPase
In cells grown to confluence on the Transwell cul-
ture inserts, we have previously observed that addition
of nontoxic concentrations of ouabain to the basolateral
aspect resulted in a dose- and time-dependent decrease
in ouabain-sensitive 86Rb uptake [11]. In this series of
studies, we observed that while administered to the ba-
solateral aspect at 50 nmol/L [approximately 0.05 × of
the acute IC50 (determined at 30 minutes of incubation)]
caused a 58 ± 4% reduction in ouabain-sensitive 86Rb
uptake after 12 hours (N = 7, P < 0.01), whereas addi-
tion of this concentration of ouabain to the apical aspect
resulted in essentially no alteration in the 86Rb uptake at
12 hours (102 ± 4% of control values, P = NS). To un-
derstand how ouabain decreased 86Rb in these cells, we
examined whether ouabain caused a reduction in surface
enzyme density. We determined the level of the surface a1
and b1 subunits of Na/K-ATPase by measuring biotiny-
lated protein densities. In response to 50 nmol/L ouabain
(12 hours) applied to the basolateral aspect, biotinylated
protein content of both the Na/K-ATPase a1 and b1 sub-
units decreased by about 60%. When ouabain was applied
to the apical aspect in the same conditions, it did not alter
the content of these biotinylated subunits (Fig. 2).
To determine the reversibility of these changes, con-
fluent monolayers of LLC-PK1 cells were subjected to
12 hours of ouabain (50 nmol/L) on the basolateral as-
pect. At this point, the ouabain was either maintained
or washed away. In monolayers in which the ouabain
was maintained, the 86Rb uptake remained low, whereas
once the ouabain was removed, the 86Rb uptake returned
to normal over the next 24 hours (Fig. 3A). Using the
same experimental design, plasmalemmal pump density
was measured using the biotinylated a1 subunit density
measurement described above. We observed that plas-







































Fig. 2. Effect of ouabain (50 nmol/L for 12 hours) on Na/K-ATPase
a1 and b1 protein density when applied to the apical or basolateral
aspects of an LLC-PK1 monolayer. (A) Representative Western blots.
(B) Quantification of N = 5 ouabain-treated experiments (5 apical and
5 basolateral) compared with N = 5 controls (values averaged and ex-
pressed as 100%). Data shown as mean ± SEM. ∗∗P < 0.01 vs. control.
To further confirm that ouabain stimulates the internal-
ization of the enzyme, confocal microscopy was utilized to
qualitatively assess the distribution of the Na/K-ATPase
in the LLC-PK1 monolayers. Cells were double-stained
with anti-a1 antibody to localize a1 subunit (green sig-
nal) and by propidium iodide (PI) to localize the nuclei
(red signal). In control, nonstimulated cells, we observed
that the a1 subunit of Na/K-ATPase was largely confined
to the basolateral aspects of the LLC-PK1 monolayer
(Fig. 4A). In these control cells, no yellow signal (in-
dicative of overlap of the green and red signals) was de-
tectable when the two images were merged. However,
in the cells treated with ouabain for 12 hours, we found
a considerable portion of the Na/K-ATPase a1 subunit
localized in internal portions of the cells (Fig. 4B). In-
terestingly, we also found that ouabain stimulated the
translocation of Na/K-ATPase into nucleus. This is con-
sistent with our earlier observation of the time-dependent
accumulation of [3H] ouabain in the nucleus of LLC-PK1
cells [11].
Because there is evidence that several receptor tyro-
sine kinases move to the nucleus where they can regulate
the transcriptional activity of their targeted genes [32–
34], we further examined whether ouabain stimulates the
translocation of Na/K-ATPase to the nucleus. To do this,
we first biotinylated the surface proteins, quenched the















































































Fig. 3. Recovery of plasmalemmal Na/K-ATPase in LLC-PK1 cell
monolayers after treatment with ouabain (50 nmol/L for 12 hours) on
the basolateral aspect. (A) Demonstrated is the recovery of ouabain-
sensitive 86Rb uptake (expressed as% control). (B) Recovery of Na/K-
ATPase a1 subunit by surface biotinylation method. Open squares
depict those from which ouabain was removed (Wash), and solid tri-
angles depict those where the ouabain concentration was maintained
(Ouabain). N = 4 experiments are represented at each data point in
each panel. ∗P < 0.05; ∗∗P < 0.01 vs. ouabain.
nonreacted biotin reagent, and then chased the biotiny-
lated proteins for 12 hours with restoration of normal
medium, with or without ouabain. To assess the possi-
bility of the contamination in the isolation process of
nuclear fraction, we also measured the biotinylated a1-
subunit without any chase to serve as a negative control.
As shown in Figure 5A, we observed that the isolation
of the nuclear compartment probably has a very small
degree of what we would characterize as contamination
during the isolation procedure, because we would not
anticipate measurable biotinylated a1-subunit to reach
the nucleus after the minimal time (5 minutes) necessary
for the isolation procedure itself. In pulse chase experi-
ments performed at 12 hours of incubation with ouabain
(50 nmol/L), we observed that ouabain induced marked
increases of a1-subunit in the nuclear fraction that was
labeled with biotin (Fig. 5A and B).
Ouabain induces Na/K-ATPase accumulation in
CCVs and endosomes and increases the association
with clathrin and AP-2
To define the mechanisms underlying this Na/K-
ATPase translocation, cells were treated with 50 nmol/L
ouabain for 1 hour, and CCV were isolated. Without
ouabain, CCVs contained relatively little Na/K-ATPase
a1 subunit, but after ouabain treatment, a considerable
amount of the sodium pump could be demonstrated
(Fig. 6). At this time point, ouabain treatment induced
a 174 ± 41% increase in CCV Na/K-ATPase a1 subunit
content (N = 4, P < 0.01). To further examine these mech-
anisms, early and late endosomes were also isolated. As
shown in Figure 7, ouabain (50 nmol/L × 2 hours) in-
duced significant increases in both early and late endoso-
mal Na/K-ATPase a1-subunit protein content. We next
labeled the a1 subunit with a monoclonal antibody, and
clathrin heavy chain with a polyclonal antibody, and then
processed these samples with an Alexa546-conjugated
secondary antibody for the Na/K-ATPase a1 subunit
(Fig. 8, left panels), and an Alexa488-conjugated sec-
ondary antibody for clathrin heavy chain (Fig. 8, middle
panels). Ouabain treatment was associated with inter-
nalization of the Na/K-ATPase (Fig. 8, bottom vs. top
panels). Moreover, marked colocalization with clathrin
was observed both before and after ouabain exposure
(Fig. 8, right panels). It should be noted that the colo-
calization of a1 subunit with clathrin mainly occurred
within the basolateral membrane in the control cells,
while the colocalization could be identified in both ba-
solateral membrane and inside the cells after ouabain
exposure.
We next used a coimmunoprecipitation assay to
examine the protein-protein interaction between the a1-
subunit and two of the major components of the clathrin-
coated pit, the AP-2 a subunit (AP-2), and the clathrin
heavy chain. As anticipated, incubation with ouabain
enhanced the interaction of the a1-subunit with AP-2
(Fig. 9). From the same lysate obtained after ouabain
treatment, ouabain increased the amount of AP-2 in the
immunoprecipitated material obtained with an antibody
against the Na/K-ATPase a1-subunit and the amount
of Na/K-ATPase a1-subunit in the immunoprecipi-
tated material obtained with an antibody against AP-2
(Fig. 9). In similar experiments addressing the protein-
protein interaction between the Na/K-ATPase a1-
subunit and clathrin, we also found that ouabain
increased the amount of Na/K-ATPase a1-subunit and
AP-2 in the immunoprecipitated material obtained with
an antibody against CHC (Fig. 9). These coimmuno-
precipitation data suggest that ouabain enhances the
protein-protein interactions of the Na/K-ATPase a1-
subunit with AP-2 a subunit and with clathrin. Ouabain
also appears to enhance the interaction of clathrin with
AP-2.
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Fig. 4. Confocal immunofluorescence images of (A) control and (B) ouabain- (50 nmol/L for 12 hours on basolateral aspect) treated LLC-PK1
cells grown to monolayer. In these images, a1 subunit of Na/K-ATPase is labeled with Alexa Fluor 488 labeled secondary antibody, giving green
fluorescence signal. Nuclei counterstained with propidium iodide (PI) (red color) for contrast. (A) Shows Z axis reconstruction, whereas (B) shows
representative XY plane. Note that the green stain is largely confined to the basolateral aspects of the control cells, whereas there is substantial
internalization of this stain in the cells treated with ouabain. Size bar = 10 lm.
Ouabain 50 nmol/L – +
Chase 12 hr
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Fig. 5. Effect of chlorpromazine (CMZ)
and potassium depletion (KD) on ouabain-
induced increases in nuclear accumulation
of biotinylated a1 subunit of Na/K-ATPase.
(A) Representative Western blot after strep-
tavidin isolation of biotinylated pump from
LLC-PK1 cell nuclei from cells exposed to
ouabain for 12 hours and control cells. Note
that there is very little biotinylated pump ap-
pearing after 5-minute chase, confirming low
levels of nuclear contamination with our isola-
tion procedure. (B) Quantification of the nu-
clear biotinylated pump (data shown as mean
± SEM of 4 individual experiments normal-
ized to the mean control value) in response
to ouabain alone vs. ouabain + CMZ or KD.
∗∗P < 0.01 vs. ouabain alone; ##P < 0.01 in
comparison with ouabain-treated cells.
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α1
Control Ouabain
50 nmol/L × 1 hour
Fig. 6. Representative Western blot illustrating effect of ouabain (1
hour at 50 nmol/L) on CCV a1 subunit of Na/K-ATPase protein content.
Both lanes loaded with 5 lg of protein. Quantification of 4 experiments
show the relative CCV Na/K-ATPase a1 subunit content in ouabain-
treated cells was 2.74 ± 0.41 (P < 0.01 vs. control) compared with CCVs
isolated from untreated cells.
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Fig. 7. Effect of ouabain (2 hours at 50 nmol/L) on early and late endo-
some a1 subunit of Na/K-ATPase protein content. (A) Representative
Western blot. (B) Quantitative data expressed as fraction of control
(control values = 1). N = 5 controls and N = 5 ouabain-treated cells
studied. ∗∗P < 0.01 vs. control.
Ouabain activates PI(3)K in LLC-PK1 cells
In a separate set of experiments, LLC-PK1 cells were
exposed to ouabain 50 nmol/L, and PI(3)K activity was
assayed. We observed that ouabain caused substantial ac-
tivation of PI(3)K by as early as 15 minutes after expo-
sure. These data are summarized in Table 2.
Inhibition of clathrin-mediated endocytosis attenuates
ouabain-stimulated Na/K-ATPase endocytosis
To confirm that ouabain-induced endocytosis of the a1-
subunit of Na/K-ATPase involves a clathrin-dependent
pathway, we first disrupted the clathrin-mediated en-
docytosis pathway by potassium depletion (KD) in
conjunction with hypotonic shock [31], or treatment
with a cationic amphiphilic drug, chlorpromazine [30].
In experiments similar to that shown in Figure 2, the
surface proteins of LLC-PK1 cells were first biotinylated,
and the nonreacted biotin reagent was quenched. Then,
the LLC-PK1 cells were exposed to ouabain (chase) for
12 hours in the presence of chlorpromazine (50 lmol/L)
or after potassium depletion. Biotinylated surface pro-
teins and nuclear fraction were isolated, and the amount
of the biotinylated Na/K-ATPase a1 subunit was deter-
mined as described above. In ouabain-stimulated cells,
both chlorpromazine and potassium depletion markedly
attenuated ouabain-induced nuclear accumulation of
the biotinylated Na/K-ATPase a1 subunit (Fig. 5B).
Ouabain-induced decreases in the plasmalemmal
Na/K-ATPase a1 subunit were also attenuated by both
chlorpromazine and potassium depletion at 12 hours.
Plasmalemmal Na/K-ATPase a1 subunit density was
decreased only 12 ± 5% and 9 ± 7% by ouabain in the
presence of chlorpromazine and potassium depletion,
respectively, compared with control.
Because activation of PI(3)K is involved in vesicular
trafficking and targeting of proteins to specific cell com-
partments (especially from clathrin-coated pits to early
endosomes) and assembly of clathrin-coated pits [28, 35],
we determined if inhibition of this enzyme attenuates
ouabain-induced endocytosis of the Na/K-ATPase. LLC-
PK1 cells were pretreated with 100 nmol/L wortmannin
for 30 minutes, then exposed to 50 nmol/L ouabain for
2 hours. Early endosomes were isolated and assayed for
the content of the Na/K-ATPase a1 subunit as described
earlier. Although wortmannin alone did not have a signif-
icant effect on this measurement, wortmannin substan-
tially attenuated the accumulation of Na/K-ATPase a1
subunit in response to ouabain as compared to ouabain
treatment alone (1.28 ± 0.07 vs. 3.4 ± 0.35 relative units,
normalized to control early endosomes, N = 12 in both
groups, P < 0.01).
In the experiments depicted in Figure 10, LLC-PK1
cells were treated with 50 nmol/L ouabain for 12 hours
in the presence or absence of 100 nmol/L wortman-
nin, then biotinylated. Wortmannin alone did not affect
biotinylated pump density but substantially attenuated
the ouabain-induced decreases in surface Na/K-ATPase
(87 ± 9% vs. 48 ± 5% control values at 12 hours, both
N = 4, P < 0.01). To further confirm the role of PI(3)K in
ouabain-induced endocytosis of Na/K-ATPase, we per-
formed 86Rb uptake studies. These studies were compli-
cated by the marked decreases in ouabain-sensitive 86Rb
uptake observed after 12-hour exposure to either wort-
mannin or LY294002. This phenomenon was observed
over a wide range of concentrations, and was not ac-
companied by evidence of cellular toxicity (e.g., altered
Trypan blue exclusion or altered microscopic appear-
ance). When these inhibitors were used at the concentra-
tions shown in Table 1 (100 nmol/L for wortmannin and
25 lmol/L for LY294002), the effect of ouabain
(50 nmol/L) to induce decreases in 86Rb uptake was
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Fig. 8. Colocalization of a1 subunit with clathrin in response to ouabain. In these images, LLC-PK1 cells were grown to monolayer, a1 subunit
of Na/K-ATPase is labeled with a Alexa Fluor 546-conjugated secondary antibody (red, right panels), and clathrin is labeled with Alexa Fluor
488-conjugated secondary antibody (middle panels). Right panels show the resultant images after merging without further processing. Top (A)
panels show cells obtained without ouabain, whereas bottom (B) panels show cells obtained after 12 hours of exposure to 50 nmol/L ouabain.
Note the compelling colocalization of the a1 subunit of Na/K-ATPase with clathrin under both control and ouabain treated conditions. Size bar =
10 lm.
markedly attenuated if we compare these values with
those observed with wortmannin and LY294002 alone.
Ouabain-induced endocytosis is not secondary
to changes in membrane potential
To address whether the ouabain-induced endocyto-
sis might be caused by changes in ion concentrations
or membrane potential, we performed the following
experiments. LLC-PK1 cells were exposed to different
potassium concentrations for 12 hours. At this time, the
cells were washed and ouabain sensitive 86Rb uptake
was measured under standard experimental conditions
(Table 3). These data demonstrate that alterations in me-
dia potassium concentration, which would be expected to
induce hypo- or hyperpolarization, did not significantly
alter 86Rb uptake and, by extension, stimulate substantial
Na/K-ATPase endocytosis.
SRC kinase is involved in ouabain-induced
a1-subunit endocytosis
Because we have previously observed that the activa-
tion of Src initiates the ouabain-activated signal trans-
duction pathway through the Na/K-ATPase in LLC-PK1
cells [17], we examined the role of Src kinase in ouabain-
induced internalization of the Na/K-ATPase. In exper-
iments depicted in Figure 11, we used the Src kinase
inhibitor, PP2, to block the activation of Src in response
to ouabain, and then examined the accumulation of
the Na/K-ATPase a1-subunit in endosomes at 2 hours
in response to ouabain. LLC-PK1 cells were first pre-
treated with 1 lmol/L PP2 for 15 minutes at 37◦C, and
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Fig. 9. Effect of ouabain (50 nmol/L for 1 hour) on the interaction be-
tween the a1-subunit of Na/K-ATPase with AP-2 and clathrin heavy
chain. (A) Representative Western blots. (B) Quantitative data. Af-
ter ouabain treatment, LLC-PK1 cell lysate from control and treated
cells was immunoprecipitated with either antibody against (IP) the
Na/K-ATPase a1−subunit, AP−2a, or clathrin heavy chain (CHC). The
immunoprecipitate was separated by SDS-PAGE and immunoblotted
(IB) with antibodies against the Na/K-ATPase a1 subunit or AP-2a.
Data shown as mean ± SEM of 4 individual experiments after ouabain
treatment compared with control. ∗∗P < 0.01 vs. control.
then treated with 50 nmol/L of ouabain (2 hours, in the
presence of PP2). As shown in Figure 11, PP2 significantly
attenuated ouabain-induced accumulation of the Na/K-
ATPase a1-subunit in early endosomes.
In additional experiments performed with SYF cells,
we isolated early and late endosomes under control cir-
cumstances, as well as 30, 60, and 120 minutes after expo-
sure to ouabain. These data are summarized in Figure 12.
We observed that in the SYF− cells, ouabain did not af-
fect the Na/K-ATPase a1 subunit density in either early
or late endosomes at any of these time points, whereas in
the reconstituted SYF+ cells, ouabain caused significant
increases in Na/K-ATPase a1 subunit density in early en-
dosomes at all time points studied, and in late endosomes
at the 120-minute time point.
DISCUSSION
The role of circulating inhibitors of Na/K-ATPase in
renal sodium homeostasis is still unclear, despite decades
of investigation [1]. Recently, it has been established that
increases in the renal excretion and plasma concentra-
tion of DLS such as MBG and OLC accompany acute
Ouabain – + – +
































Fig. 10. Effect of PI(3)K inhibitor on ouabain-induced decrease of sur-
face Na/K-ATPase a1-subunit. (A) Representative Western blots. (B)
Quantitative data expressed as mean ± SEM of 4 individual experi-
ments normalized to the mean control value. LLC-PK1 cells (grown
on Transwell culture inserts) were preincubated with 100 nmol/L wort-
mannin for 30 minutes, and then exposed to 50 nmol/L ouabain for 12
hours (on basolateral aspect). Biotinylated a1-subunit was determined
as in Figure 1. ∗∗P < 0.01 vs. control.
Table 1. Effect of PI(3)K inhibitors on ouabain-induced decreases in
86Rb uptake
Experimental 86Rb uptake
group (N) (fraction control)
Ouabain (8) 45.6 ± 4.1b
Wortmannin (5) 82.5 ± 6.4a
Ly294002 (5) 80.4 ± 5.8a
Wortmannin + ouabain (5) 61.6 ± 3.8b,c
Ly294002 + ouabain (5) 64.6 ± 5.4b,c
Doses of pharmacologic agents: ouabain, 50 nmol/L; wortmannin, 100 nmol/L;
LY294002, 25 lmol/L. All agents were administered for 12 hours. Fresh media
(with agents) were changed every 4 hours.
aP < 0.05; bP < 0.01 vs control; cP < 0.05 vs. ouabain alone.
Table 2. Effect of ouabain (50 nmol/L) on PI(3)K activity
Time of ouabain PI(3)K activity
exposure minutes % control
5 98.7 ± 2.1a
15 165.3 ± 8.5b
30 144.0 ± 7.4b
Data expressed as % control value ± SEM from N = 6 determinations.
aP < 0.05; bP < 0.01 vs. control.
volume expansion in the Dahl salt-sensitive rat, and that
administration of antibody to cardiac glycoside blocks
both the hypertension and the increases in urinary sodium
excretion seen in this setting [5]. However, the mecha-
nism(s) by which picomolar circulating concentrations of
DLS can markedly attenuate renal sodium reabsorption
is (are) still unclear.
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Table 3. Effect of altered potassium concentration for 12 hours on
86Rb uptake [performed under standard experimental conditions (i.e.,
K = 5.3 mmol/L)]
Potassium concentration 86Rb uptake
(all N = 6) (fraction control)
K = 1 mmol/L 95.7 ± 4.3
K = 3 mmol/L 96.8 ± 6.2
K = 7 mmol/L 97.2 ± 2.8
K = 10 mmol/L 96.9 ± 2.7
Data expressed as % control value ± SEM. No value was significantly
different from control (K = 5.3 mmol/L).
Ouabain – – + +
PP2
OuabainPP2 PP2 + Ouabain 






























Fig. 11. Effect of Src kinase inhibitor on ouabain-induced accumula-
tion of a1-subunit in endosomes. LLC-PK1 cells were preincubated with
1 lmol/L PP2 for 15 minutes, and then exposed to 50 nmol/L of ouabain
for 2 hours in the continued presence of PP2. (A) Representative West-
ern blot. (B) Quantitative data expressed as fraction of control (control
values = 1). Quantitative data derived from 3 individual experiments.
∗∗P < 0.01 in comparison with control and PP2 alone; ##P < 0.01 in
comparison with ouabain-treated cells.
In this report, we make several important observations.
First, a very low concentration of ouabain (50 nmol/L)
rapidly induces endocytosis of the Na/K-ATPase. After
this process continues for several hours, substantial de-
pletion of the sodium pump density and function on the
membrane surface in LLC-PK1 cells can be measured. In
fact, the decrease in the surface a1 subunit was in concert
with the decrease in the b1 subunit of the Na/K-ATPase,
suggesting that ouabain binds to and removes the whole
a1b1 complex from the plasmalemma. We also noted that
essentially complete recovery from 12-hour exposure to
this dose occurs within 12 to 24 hours. This observation
provides an explanation by which circulating concentra-
tions of DLS might decrease proximal tubular sodium








































Fig. 12. Effect of ouabain (10 lmol/L) on accumulation of Na/K-
ATPase a1-subunit in early (EE) and late (LE) endosomes of SYF+
and SYF− cells. Data expressed as fraction of control (i.e., compared
with no ouabain in the respective cell type), and shown as mean ± SEM
of 5 experiments. ∗P < 0.05 and ∗∗P < 0.01 compared with control.
ouabain-stimulated endocytosis of the Na/K-ATPase ap-
pears to involve clathrin-dependent mechanisms. Third,
and perhaps most interesting, we found that inhibition
of the signal transduction cascade initiated by ouabain
through the Na/K-ATPase at the level of Src also atten-
uated the endocytosis pathway. This latter point, to our
minds, is so important because it completes the analogy of
signal transduction through the Na/K-ATPase with more
conventional receptor ligand systems [36].
Endocytosis of the Na/K-ATPase, especially in re-
sponse to dopamine, has been clearly demonstrated [28,
37]. In addition, early studies from the laboratories
of Cook and Lamb demonstrated that ouabain-bound
Na/K-ATPase translocated from the plasmalemmal to in-
tracellular compartments [38, 39]. In our previous report
we observed that ouabain and marinobufagenin could
induce substantial decreases in Na/K-ATPase activity (as-
sayed as ouabain-sensitive 86Rb uptake as well as enzy-
matic activity) and plasmalemmal Na/K-ATPase protein
content (as assayed by both ouabain binding and biotiny-
lation) in LLC-PK1 cells, which we used as a model for
proximal renal tubule epithelial cells [11].
Endocytosis of many different receptors, including G-
protein–coupled receptors and receptor tyrosine kinases,
is mediated through clathrin-mediated pathways. This
process is initiated by tyrosine phosphorylation followed
by recruitment and activation of PI(3)K, which lead
to assembly of clathrin-coated pits [28, 35]. Recently,
there has been ample evidence that Na/K-ATPase can
function as a signal transducer as well as an ion pump.
Binding of ouabain to the Na/K-ATPase activates Src,
resulting in transactivation of EGFR and PI(3)K in LLC-
PK1 cells [16, 17, 40]. Based on the findings presented in
this report, we suggest that ouabain may actually induce
the formation of an Na/K-ATPase/Src/EGFR/PI(3)K
















Fig. 13. Schematic representation of the ouabain-induced endocytosis of Na/K-ATPase. Na/K-ATPase depicted show binding to ouabain (Oua,
blue oval), Src (purple oval), EGFR (dark green oval), and later PI(3)K (light green oval) and AP2 (light blue oval). Possible fates, including
degradation in lysosomes, recycling to the plasmalemma, and translocation to the nucleus for signaling are illustrated.
complex, and this complex recruits AP-2 and clathrin to
form the clathrin-coated pits, resulting in the endocytosis
of the enzyme (Fig. 13). This proposal is further supported
by the following evidence. First, it is well established
that potassium depletion inhibits this pathway by block-
ing clathrin-coated pit formation [41], and that chlor-
promazine causes a decrease in the assembly of coated
pits on the cell surface and an increase of clathrin lat-
tice assembly on endosomal membranes [30]. In our ex-
periments, both chlorpromazine and potassium depletion
treatments did not affect cell viability, but resulted in a sig-
nificant attenuation of the ouabain-induced endocytosis
of the a1-subunit of Na/K-ATPase. Moreover, inhibition
of Src or PI(3)K blocked ouabain-induced accumulation
of the Na/K-ATPase a1 subunit in early endosomes. Ad-
ditional experiments performed with the SYF cell lines
further confirmed that Src family kinases are required
for ouabain-induced endocytosis of the sodium pump
to proceed. Also, on a molecular level, ouabain stimu-
lated the interactions among the Na/K-ATPase, AP-2,
and clathrin. These data provide substantial evidence
that ouabain induces endocytosis of the Na/K-ATPase
through a clathrin-dependent mechanism. Because the
doses of ouabain employed would not be expected to sub-
stantially alter cytosolic sodium [18, 42], and because hy-
popolarization (or hyperpolarization) of the membrane
did not cause major changes in 86Rb uptake, we further
suggest that ouabain-induced endocytosis of the Na/K-
ATPase is part of, or a direct consequence of, signal trans-
duction through the Na/K-ATPase.
Although dopamine-mediated endocytosis also pro-
ceeds through a clathrin-dependent pathway [13, 43], we
do not yet know how much overlap there is between
dopaminergic and ouabain-induced Na/K-ATPase en-
docytosis. Endocytosis of Na/K-ATPase in response to
dopamine is triggered by the phosphorylation of Ser18
and activation of PI(3)K [44]. The binding and activation
of PI(3)K facilitates the binding of the a1-subunit with
adaptor AP-2 protein, providing the inclusion of Na/K-
ATPase into clathrin vesicles. However, Ser18 is found
only in rat a1-subunit and is not present in pig and dog
a1-subunit [45]. This indicates that ouabain- and
dopamine-induced Na/K-ATPase endocytosis may fol-
low different initial steps and common postendocytic
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steps. Interestingly, Chibalin et al found that ouabain at
1 mmol/L did not induce detectable increases in endoso-
mal a1 content at 2.5 minutes in the rat proximal tubule
preparation [13]. However, this dose of ouabain is ap-
proximately 10× the IC50 for the a1 isoform in the rat,
and it is likely that this dose of ouabain is quite toxic to
these cells.
In cardiac myocytes and several other cell types (in-
cluding LLC-PK1 cells), Na/K-ATPase, in response to
nontoxic concentrations of ouabain, interacts with other
membrane proteins to relay signals to intracellular signal-
ing complexes, mitochondria, and the nucleus. This led to
the activation of multiple signal transduction cascades, in-
cluding protein kinase C (PKC), Ras/Raf/MEK/MAPK
[46, 47], and increased production of reactive oxygen
species, which results in the activation of transcription
factor AP-1 and nuclear factor jB (NF-jB), and alter-
ation of the transcriptional regulation of several growth-
related genes [48].
From our observations, it is very clear that there is con-
siderable opportunity for “cross-talk” between ouabain-
induced signaling pathways and ouabain-induced
endocytosis of Na/K-ATPase. While receptor-mediated
endocytosis has been traditionally considered an effec-
tive mechanism to attenuate ligand-activated responses,
more recent observations have led to the view that
signaling continues on the endocytic pathway, including
from endosomes [49, 50]. Endocytic vesicles can function
as a signaling compartment distinct from the plasma
membrane, and endocytosis plays an important role in
the activation and propagation of signaling pathways.
It appears that endocytosis of activated EGFR, which
recruits signaling proteins directly onto endosomes, is
necessary for full-scale mitogen-activated protein kinase
(MAPK) activation. MEK1-ERK complex could be
formed intracellularly, and activated Ras, Raf1, and
MAP kinase/ERK kinase (MEK) can be found on
endosomes [51]. In some circumstances, endocytosis
is necessary to allow the signaling protein complex,
like MEK1, access to extracellular signal-regulated
protein kinase (ERKs) in an intracellular compartment
[52], and H-Ras signaling through Raf/MEK/MAPK
requires endocytosis and endocytic recycling [53]. On
the other hand, signal transduction can also regulate
endocytosis. For example, EGF stimulation causes
rapid phosphorylation of clathrin heavy chain in an
Src-dependent process, which leads to increased recruit-
ment of clathrin onto the plasma membrane [54], and
over-expression of c-Src increases the rate of endocytosis
of EGF/EGFR complexes [55]. As discussed above,
ouabain inhibits Na/K-ATPase activity and induces
endocytosis of the enzyme; ouabain also activates Src
and PI(3)K (both involved in ouabain-induced endo-
cytosis of Na/K-ATPase), and transactivates EGFR,
leading to the activation of MAPK. It is therefore
quite reasonable to propose that there is cross-talk
between ouabain-induced Na/K-ATPase endocytosis
and ouabain-induced signaling transduction. In other
studies examining signal transduction in myocytes, our
group has observed that caveolae may also be involved
in signal transduction resulting in changes in cytosolic
calcium and inotropy [56, 57]. This, of course, raises the
possibilities that interactions between the Na/K-ATPase
and caveolins, as well as caveolins and proteins important
in clathrin-dependent endocytosis, may also be involved
in the endocytosis pathway in renal epithelium examined
in this paper. Certainly, additional studies are necessary
to examine these extremely important issues in detail.
In this report, we observed that some of the Na/K-
ATPase appears to translocate to the cell nucleus after
ouabain stimulation. While we must concede that con-
tamination of the nuclear preparation with endosomes or
plasmalemma after ouabain could potentially obfuscate
our findings, we stress that our isolation procedure should
minimize such contamination. Although it is not yet clear
what role endocytosis may play in the Na/K-ATPase sig-
nal cascade, this translocation of Na/K-ATPase into the
nucleus immediately suggests two potential mechanisms.
First, it is possible that translocation of the pump to
the nucleus allows for an active sodium “pump” to be
inserted into the nuclear membrane, where changes in
ion concentrations across this membrane might result as
recently suggested [58]. Alternately, the Na/K-ATPase
a1 subunit (or a fragment of this subunit) might actu-
ally be transported into the nucleus, where it might have
direct genomic effects. Specifically, we would speculate
that the translocation of the Na/K-ATPase to the nu-
cleus would induce down-regulation of other ion pumps
important in sodium handling by the proximal tubule,
such as the NaH(3) exchanger. Down-regulation of these
ion pumps is known to occur in proximal tubules in
vivo during salt loading [59]. The presence of the full-
length Na/K-ATPase a1-subunit and the accumulation
of [3H]ouabain in the nucleus is, however, also consistent
with previous reports [60]. Moreover, our Western blot
studies would argue against degradation or modification
of the a1-subunit along the endocytic pathway because
the a1-subunit found in the nucleus is identical to that
of the plasma membrane on SDS-PAGE analysis; this
suggests that the catalytic a1-subunit of Na/K-ATPase
may be still functional as a ion transporter or as a tran-
scriptional regulator on the nuclear membrane or inside
the nucleus. It was shown that an intramolecular domain
(Ser692-Ser740) of chicken Na/K-ATPase a1-subunit fused
with the GAL4 DNA binding domain can regulate re-
porter gene expression in yeast and mammalian cells [60].
To further support this concept, many transmembrane re-
ceptors have also been detected in the nucleus [61], such
as the receptors for EGF [32] and insulin [62]. Nuclear
localization might therefore be a general feature of many
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transmembrane receptors. Interestingly, after transloca-
tion to the nucleus, the EGFR appears to directly affect
gene expression [32]. However, further studies are neces-
sary to examine whether endosomal and nuclear translo-
cated a1-subunits do communicate with ouabain-induced
signaling pathways and contribute to ouabain-induced
gene regulation.
CONCLUSION
We demonstrated that low concentrations of ouabain
induce substantial endocytosis of the Na/K-ATPase in a
clathrin-dependent manner. Further studies will be nec-
essary to define the degree of overlap and cross-talk with
the dopaminergic pathway, the role that the internalized
Na/K-ATPase plays in ouabain- or DLS-induced signal
transduction, and the in vivo physiologic importance of
this pathway with respect to renal sodium handling.
ACKNOWLEDGMENTS
Some of these data were presented in abstract form at the 2002 and
2003 American Society of Nephrology Meetings. The authors would like
to thank Ms. Carol Woods for her excellent secretarial assistance. Por-
tions of this study were supported by the National Institutes of Health
(HL57144, HL63238, and HL67963).
Reprint requests to Joseph I. Shapiro, M.D., Chairman, Department




1. DE WARDENER HE: Franz Volhard Lecture 1996. Sodium transport
inhibitors and hypertension. J Hypertens 14(Suppl):S9–18, 1996
2. CAPLAN MJ: Ion pumps in epithelial cells: Sorting, stabilization, and
polarity. Am J Physiol 272:G1304–G1313, 1997
3. LINGREL JB, VAN HUYSSE J, O’BRIEN W, et al: Structure-function
studies of the Na,K-ATPase. Kidney Int 44:S32–S39, 1994
4. BRICKER NS: The control of sodium excretion with normal and re-
duced nephron populations. The pre-eminence of third factor. Am
J Med 43:313–321, 1967
5. FEDOROVA OV, KOLODKIN NI, AGALAKOVA NI, et al: Marinobufa-
genin, an endogenous alpha-1 sodium pump ligand, in hypertensive
Dahl salt-sensitive rats. Hypertension 37:462–466, 2001
6. GONICK HC, DING Y, VAZIRI ND, et al: Simultaneous measurement
of marinobufagenin, ouabain, and hypertension-associated protein
in various disease states. Clin Exp Hypertens 20:617–627, 1998
7. KENNEDY D, OMRAN E, PERIYASAMY SM, et al: Effect of chronic
renal failure on cardiac contractile function, calcium cycling, and
gene expression of proteins important for calcium homeostasis in
the rat. J Am Soc Nephrol 14:90–97, 2003
8. HAMLYN JM, BLAUSTEIN MP, BOVA S, et al: Identification and charac-
terization of an ouabain-like compound from human plasma. Proc
Natl Acad Sci USA 88:6259–6263, 1991
9. FEDOROVA OV, TALAN MI, AGALAKOVA NI, et al: Endogenous ligand
of alpha(1) sodium pump, marinobufagenin, is a novel mediator
of sodium chloride–dependent hypertension. Circulation 105:1122–
1127, 2002
10. DORIS P: Regulation of Na,K-ATPase by endogenous ouabain-like
materials. Proc Soc Exp Biol Med 205:202–212, 1994
11. LIU J, PERIYASAMY SM, GUNNING W, et al: Effects of cardiac gly-
cosides on sodium pump expression and function in LLC-PK1 and
MDCK cells. Kidney Int 62:2118–2125, 2002
12. OGIMOTO G, YUDOWSKI GA, BARKER CJ, et al: G protein-coupled re-
ceptors regulate Na+,K+-ATPase activity and endocytosis by mod-
ulating the recruitment of adaptor protein 2 and clathrin. Proc Natl
Acad Sci USA 97:3242–3247, 2000
13. CHIBALIN AV, KATZ AI, BERGGREN PO, BERTORELLO AM: Receptor-
mediated inhibition of renal Na(+)-K(+)-ATPase is associated
with endocytosis of its alpha- and beta-subunits. Am J Physiol
273:C1458–1465, 1997
14. SETO ES, BELLEN HJ, LLOYD TE: When cell biology meets devel-
opment: Endocytic regulation of signaling pathways. Genes Dev
16:1314–1336, 2002
15. CAVALLI V, CORTI M, GRUENBERG J: Endocytosis and signaling cas-
cades: A close encounter. FEBS Lett 498:190–196, 2001
16. HAAS M, ASKARI A, XIE Z: Involvement of Src and epidermal growth
factor receptor in the signal-transducing function of Na+/K+-
ATPase. J Biol Chem 275:27832–27837, 2000
17. HAAS M, WANG H, TIAN J, XIE Z: Src-mediated inter-receptor cross-
talk between the Na+/K+-ATPase and the epidermal growth factor
receptor relays the signal from ouabain to mitogen-activated protein
kinases. J Biol Chem 277:18694–18702, 2002
18. LIU J, TIAN J, HAAS M, et al: Ouabain interaction with car-
diac Na+/K+-ATPase initiates signal cascades independent of
changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem
275:27838–27844, 2000
19. SORKIN A, VON ZASTROW M: Signal transduction and endocytosis:
Close encounters of many kinds. Nat Rev Mol Cell Biol 3:600–614,
2002
20. YOUNG MA, GONFLONI S, SUPERTI-FURGA G, et al: Dynamic coupling
between the SH2 and SH3 domains of c-Src and Hck underlies their
inactivation by C-terminal tyrosine phosphorylation. Cell 105:115–
126, 2001
21. GORVEL JP, CHAVRIER P, ZERIAL M, GRUENBERG J: Rab5 controls
early endosome fusion in vitro. Cell 64:915–925, 1991
22. HAMMOND TG, VERROUST PJ: Trafficking of apical proteins into
clathrin-coated vesicles isolated from rat renal cortex. Am J Physiol
266:F554–562, 1994
23. GOTTARDI CJ, CAPLAN MJ: Delivery of Na+,K(+)-ATPase in polar-
ized epithelial cells. Science 260:552–554, 1993
24. GOTTARDI CJ, DUNBAR LA, CAPLAN MJ: Biotinylation and assess-
ment of membrane polarity: Caveats and methodological concerns.
Am J Physiol 268:F285–295, 1995
25. SORKIN A, MCKINSEY T, SHIH W, et al: Stoichiometric interaction of
the epidermal growth factor receptor with the clathrin-associated
protein complex AP-2. J Biol Chem 270:619–625, 1995
26. STODDART A, DYKSTRA ML, BROWN BK, et al: Lipid rafts unite sig-
naling cascades with clathrin to regulate BCR internalization. Im-
munity 17:451–462, 2002
27. MUTH TR, GOTTARDI CJ, ROUSH DL, CAPLAN MJ: A basolateral
sorting signal is encoded in the alpha-subunit of Na-K-ATPase. Am
J Physiol 274:C688–696, 1998
28. CHIBALIN AV, ZIERATH JR, KATZ AI, et al: Phosphatidylinositol 3–
Kinase-mediated endocytosis of renal Na+,K+-ATPase alpha sub-
unit in response to dopamine. Mol Biol Cell 9:1209–1220, 1998
29. SUBTIL A, HEMAR A, DAUTRY-VARSAT A: Rapid endocytosis of inter-
leukin 2 receptors when clathrin-coated pit endocytosis is inhibited.
J Cell Sci 107:3461–3468, 1994
30. WANG LH, ROTHBERG KG, ANDERSON RG: Mis-assembly of clathrin
lattices on endosomes reveals a regulatory switch for coated pit
formation. J Cell Biol 123:1107–1117, 1993
31. LARKIN JM, BROWN MS, GOLDSTEIN JL, ANDERSON RG: Depletion
of intracellular potassium arrests coated pit formation and receptor-
mediated endocytosis in fibroblasts. Cell 33:273–285, 1983
32. LIN SY, MAKINO K, XIA W, et al: Nuclear localization of EGF re-
ceptor and its potential new role as a transcription factor. Nat Cell
Biol 3:802–808, 2001
33. NI CY, MURPHY MP, GOLDE TE, CARPENTER G: Gamma -secretase
cleavage and nuclear localization of ErbB-4 receptor tyrosine ki-
nase. Science 294:2179–2181, 2001
34. XIE Y, HUNG MC: Nuclear localization of p185neu tyrosine kinase
and its association with transcriptional transactivation. Biochem
Biophys Res Commun 203:1589–1598, 1994
35. DE CAMILLI P, EMR SD, MCPHERSON PS, NOVICK P: Phosphoinosi-
tides as regulators in membrane traffic. Science 271:1533–1539, 1996
Liu et al: Ouabain-induced endocytosis of the sodium pump 241
36. XIE Z, ASKARI A: Na(+)/K(+)-ATPase as a signal transducer. Eur
J Biochem 269:2434–2439, 2002
37. CHIBALIN AV, OGIMOTO G, PEDEMONTE CH, et al: Dopamine-
induced endocytosis of Na+,K+-ATPase is initiated by phospho-
rylation of Ser-18 in the rat alpha subunit and is responsible for the
decreased activity in epithelial cells. J Biol Chem 274:1920–1927,
1999
38. COOK JS, TATE EH, SHAFFER C: Uptake of [3H]ouabain from the
cell surface into the lysosomal compartment of HeLa cells. J Cell
Physiol 110:84–92, 1982
39. ALGHARABLY N, OWLER D, LAMB JF: The rate of uptake of cardiac
glycosides into human cultured cells and the effects of chloroquine
on it. Biochem Pharmacol 35:3571–3581, 1986
40. ZHOU X, JIANG G, ZHAO A, et al: Inhibition of Na,K-ATPase acti-
vates PI3 kinase and inhibits apoptosis in LLC-PK1 cells. Biochem
Biophys Res Commun 285:46–51, 2001
41. LARKIN JM, DONZELL WC, ANDERSON RG: Potassium-dependent
assembly of coated pits: New coated pits form as planar clathrin
lattices. J Cell Biol 103:2619–2627, 1986
42. MUTO S, NEMOTO J, OKADA K, et al: Intracellular Na+ directly mod-
ulates Na+,K+-ATPase gene expression in normal rat kidney ep-
ithelial cells. Kidney Int 57:1617–1635, 2000
43. DONE SC, LEIBIGER IB, EFENDIEV R, et al: Tyrosine 537 within the
Na+,K+-ATPase alpha-subunit is essential for AP-2 binding and
clathrin-dependent endocytosis. J Biol Chem 277:17108–17111, 2002
44. YUDOWSKI GA, EFENDIEV R, PEDEMONTE CH, et al:
Phosphoinositide-3 kinase binds to a proline-rich motif in the
Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc
Natl Acad Sci USA 97:6556–6561, 2000
45. FESCHENKO MS, SWEADNER KJ: Structural basis for species-specific
differences in the phosphorylation of Na,K-ATPase by protein ki-
nase C. J Biol Chem 270:14072–14077, 1995
46. KOMETIANI P, LI J, GNUDI L, et al: Multiple signal transduction path-
ways link Na+/K+-ATPase to growth-related genes in cardiac my-
ocytes. The roles of ras and mitogen-activated protein kinases. J Biol
Chem 273:15249–15256, 1998
47. MOHAMMADI K, KOMETIANI P, XIE Z, ASKARI A: Role of protein ki-
nase C in the signal pathways that link Na+/K+-ATPase to ERK1/2.
J Biol Chem 276:42050–42056, 2001
48. XIE Z, KOMETIANI P, LIU J, et al: Intracellular reactive oxygen species
mediate the linkage of Na+/K+-ATPase to hypertrophy and its
marker genes in cardiac myocytes. J Biol Chem 274:19323–19328,
1999
49. FELBERBAUM-CORTI M, GRUENBERG J: Signaling from the far side.
Mol Cell 10:1259–1260, 2002
50. MCPHERSON PS, KAY BK, HUSSAIN NK: Signaling on the endocytic
pathway. Traffic 2:375–384, 2001
51. DI GUGLIELMO GM, BAASS PC, OU WJ, et al: Compartmentalization
of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by
EGF but not insulin in liver parenchyma. EMBO J 13:4269–4277,
1994
52. KRANENBURG O, VERLAAN I, MOOLENAAR WH: Dynamin is required
for the activation of mitogen-activated protein (MAP) kinase by
MAP kinase kinase. J Biol Chem 274:35301–35304, 1999
53. ROY S, WYSE B, HANCOCK JF: H-Ras signaling and K-Ras signaling
are differentially dependent on endocytosis. Mol Cell Biol 22:5128–
5140, 2002
54. WILDE A, BEATTIE EC, LEM L, et al: EGF receptor signal-
ing stimulates SRC kinase phosphorylation of clathrin, influ-
encing clathrin redistribution and EGF uptake. Cell 96:677–687,
1999
55. WARE MF, TICE DA, PARSONS SJ, LAUFFENBURGER DA: Overexpres-
sion of cellular Src in fibroblasts enhances endocytic internalization
of epidermal growth factor receptor. J Biol Chem 272:30185–30190,
1997
56. XIE Z: Molecular mechanisms of Na/K-ATPase-mediated signal
transduction. Ann N Y Acad Sci 986:497–503, 2003
57. LIU L, MOHAMMADI K, AYNAFSHAR B, et al: Role of caveolae in signal-
transducing function of cardiac Na+/K+-ATPase. Am J Physiol Cell
Physiol 284:C1550–1560, 2003
58. GARNER MH: Na,K-ATPase in the nuclear envelope regulates Na+:
K+ gradients in hepatocyte nuclei. J Membr Biol 187:97–115,
2002
59. AMLAL H, CHEN Q, GREELEY T, et al: Coordinated down-regulation
of NBC-1 and NHE-3 in sodium and bicarbonate loading. Kidney
Int 60:1824–1836, 2001
60. YOSHIMURA SH, OHNIWA LS, OGITA Y, and TAKEYASU K: The sodium
pump goes to the nucleus: When, how and Why?, in Na/K-ATPase
and Related ATPase, edited by Taniguchi K, Kaya S, Sapporo, Japan,
Elsevier Science, 2000, pp 625–631
61. JANS DA, HASSAN G: Nuclear targeting by growth factors, cytokines,
and their receptors: A role in signaling? Bioessays 20:400–411,
1998
62. VIGNERI R, GOLDFINE ID, WONG KY, et al: The nuclear envelope.
The major site of insulin binding in rat liver nuclei. J Biol Chem
253:2098–2103, 1978
